Gregory M. Weinhoff
Chief Business Officer · Centessa Pharmaceuticals plc
- 2024
- Jun 24, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregory M. Weinhoff files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Karen M. Anderson - $9.65M in CNTA purchases and sales in the last 12 months
- Tia L. Bush - $2.16M in CNTA purchases and sales in the last 12 months
- Iqbal J. Hussain - $1.17M in CNTA purchases and sales in the last 12 months
- Mario Alberto Accardi - $200K in CNTA purchases and sales in the last 12 months
- Medicxi Ventures Management (Jersey) Ltd - CNTA
- INDEX VENTURES LIFE VI (JERSEY) L.P. - CNTA
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregory M. Weinhoff?
Gregory M. Weinhoff is a corporate insider, tracked as Chief Business Officer of Centessa Pharmaceuticals plc (CNTA). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Gregory M. Weinhoff last file a Form 4?
The most recent primary Form 4 on record is dated 24 June 2026, one of 10 filings going back to 2024.
Has Gregory M. Weinhoff been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($3.33M) across all tracked filings.
